Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1859 1
1867 1
1898 1
1905 1
1910 1
1921 1
1926 1
1928 2
1929 1
1930 1
1931 2
1933 1
1935 1
1936 6
1937 1
1938 2
1939 2
1940 1
1941 5
1942 1
1943 2
1946 3
1947 9
1948 10
1949 8
1950 17
1951 12
1952 18
1953 24
1954 22
1955 24
1956 19
1957 19
1958 25
1959 32
1960 33
1961 34
1962 36
1963 36
1964 50
1965 42
1966 49
1967 47
1968 47
1969 89
1970 130
1971 128
1972 98
1973 85
1974 88
1975 277
1976 284
1977 228
1978 242
1979 221
1980 235
1981 231
1982 241
1983 262
1984 286
1985 282
1986 288
1987 300
1988 307
1989 397
1990 415
1991 422
1992 411
1993 485
1994 476
1995 479
1996 513
1997 533
1998 532
1999 569
2000 688
2001 789
2002 702
2003 876
2004 870
2005 1040
2006 1207
2007 1248
2008 1365
2009 1506
2010 1626
2011 1733
2012 1797
2013 2101
2014 2607
2015 2958
2016 3110
2017 3134
2018 3619
2019 4134
2020 5063
2021 5618
2022 5690
2023 5857
2024 1233

Text availability

Article attribute

Article type

Publication date

Search Results

63,557 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: Shokrabi
Page 1
Considerations for the use of SH-SY5Y neuroblastoma cells in neurobiology.
Kovalevich J, Langford D. Kovalevich J, et al. Methods Mol Biol. 2013;1078:9-21. doi: 10.1007/978-1-62703-640-5_2. Methods Mol Biol. 2013. PMID: 23975817 Free PMC article.
Originally derived from a metastatic bone tumor biopsy, SH-SY5Y (ATCC() CRL-2266) cells are a subline of the parental line SK-N-SH (ATCC() HTB-11). SK-N-SH were subcloned three times; first to SH-SY, then to SH-SY5, and finally to SH-SY5Y …
Originally derived from a metastatic bone tumor biopsy, SH-SY5Y (ATCC() CRL-2266) cells are a subline of the parental line SK-N-SH
Considerations for the Use of SH-SY5Y Neuroblastoma Cells in Neurobiology.
Kovalevich J, Santerre M, Langford D. Kovalevich J, et al. Methods Mol Biol. 2021;2311:9-23. doi: 10.1007/978-1-0716-1437-2_2. Methods Mol Biol. 2021. PMID: 34033074
Originally derived from a metastatic bone tumor biopsy, SH-SY5Y (ATCC() CRL-2266) cells are a subline of the parental line SK-N-SH (ATCC() HTB-11). SK-N-SH were subcloned three times; first to SH-SY, then to SH-SY5, and finally to SH-SY5Y …
Originally derived from a metastatic bone tumor biopsy, SH-SY5Y (ATCC() CRL-2266) cells are a subline of the parental line SK-N-SH
Endometrial carcinosarcoma.
Bogani G, Ray-Coquard I, Concin N, Ngoi NYL, Morice P, Caruso G, Enomoto T, Takehara K, Denys H, Lorusso D, Coleman R, Vaughan MM, Takano M, Provencher DM, Sagae S, Wimberger P, Póka R, Segev Y, Kim SI, Kim JW, Candido Dos Reis FJ, Ramirez PT, Mariani A, Leitao M, Makker V, Abu-Rustum NR, Vergote I, Zannoni G, Tan D, McCormack M, Paolini B, Bini M, Raspagliesi F, Benedetti Panici P, Di Donato V, Muzii L, Colombo N, Pignata S, Scambia G, Monk BJ. Bogani G, et al. Int J Gynecol Cancer. 2023 Feb 6;33(2):147-174. doi: 10.1136/ijgc-2022-004073. Int J Gynecol Cancer. 2023. PMID: 36585027 Review.
Clear cell carcinoma of the endometrium.
Bogani G, Ray-Coquard I, Concin N, Ngoi NYL, Morice P, Enomoto T, Takehara K, Denys H, Lorusso D, Coleman R, Vaughan MM, Takano M, Provencher D, Sagae S, Wimberger P, Póka R, Segev Y, Kim SI, Kim JW, Candido Dos Reis FJ, Mariani A, Leitao MM Jr, Makker V, Rustum NA, Vergote I, Zannoni GF, Tan DSP, McCormack M, Bini M, Lopez S, Raspagliesi F, Panici PB, di Donato V, Muzii L, Colombo N, Scambia G, Pignata S, Monk BJ. Bogani G, et al. Gynecol Oncol. 2022 Mar;164(3):658-666. doi: 10.1016/j.ygyno.2022.01.012. Epub 2022 Jan 19. Gynecol Oncol. 2022. PMID: 35063279 Review.
Uterine serous carcinoma.
Bogani G, Ray-Coquard I, Concin N, Ngoi NYL, Morice P, Enomoto T, Takehara K, Denys H, Nout RA, Lorusso D, Vaughan MM, Bini M, Takano M, Provencher D, Indini A, Sagae S, Wimberger P, Póka R, Segev Y, Kim SI, Candido Dos Reis FJ, Lopez S, Mariani A, Leitao MM Jr, Raspagliesi F, Panici PB, Di Donato V, Muzii L, Colombo N, Scambia G, Pignata S, Monk BJ. Bogani G, et al. Gynecol Oncol. 2021 Jul;162(1):226-234. doi: 10.1016/j.ygyno.2021.04.029. Epub 2021 Apr 30. Gynecol Oncol. 2021. PMID: 33934848 Free PMC article. Review.
Gestational choriocarcinoma.
Bogani G, Ray-Coquard I, Mutch D, Vergote I, Ramirez PT, Prat J, Concin N, Ngoi NYL, Coleman RL, Enomoto T, Takehara K, Denys H, Lorusso D, Takano M, Sagae S, Wimberger P, Segev Y, Kim SI, Kim JW, Herrera F, Mariani A, Brooks RA, Tan D, Paolini B, Chiappa V, Longo M, Raspagliesi F, Benedetti Panici P, Di Donato V, Caruso G, Colombo N, Pignata S, Zannoni G, Scambia G, Monk BJ. Bogani G, et al. Int J Gynecol Cancer. 2023 Oct 2;33(10):1504-1514. doi: 10.1136/ijgc-2023-004704. Int J Gynecol Cancer. 2023. PMID: 37758451 Review.
Secondary hypertension: evaluation and management.
Tandan N, Lavie CJ, Stewart MH, Milani RV, Ventura HO. Tandan N, et al. Curr Opin Cardiol. 2023 Jul 1;38(4):318-325. doi: 10.1097/HCO.0000000000001059. Epub 2023 Apr 25. Curr Opin Cardiol. 2023. PMID: 37115960 Review.
PURPOSE OF REVIEW: Hypertension (HTN) that can be attributed to a particular source is known as secondary HTN (SH). Often, SH is difficult to control and thus referred to as resistant HTN, although the two terms are not mutually exclusive. ...The key to effective ma …
PURPOSE OF REVIEW: Hypertension (HTN) that can be attributed to a particular source is known as secondary HTN (SH). Often, SH
A novel method for generating glutamatergic SH-SY5Y neuron-like cells utilizing B-27 supplement.
Martin ER, Gandawijaya J, Oguro-Ando A. Martin ER, et al. Front Pharmacol. 2022 Oct 20;13:943627. doi: 10.3389/fphar.2022.943627. eCollection 2022. Front Pharmacol. 2022. PMID: 36339621 Free PMC article.
SH-SY5Y cells cultured in FBS or under serum-starved conditions were used as controls. ...These findings suggest that B-27 may be a non-toxic inducer of glutamatergic SH-SY5Y differentiation. Our study demonstrates a novel way of using B-27 to obtain populations of
SH-SY5Y cells cultured in FBS or under serum-starved conditions were used as controls. ...These findings suggest that B-27 may be a n
Topical application of sh-oligopeptide-1 and clinical trials with cosmetic preparations: risk or fraud?
Martínez-Carpio PA. Martínez-Carpio PA. Cutan Ocul Toxicol. 2023 Dec;42(4):190-197. doi: 10.1080/15569527.2023.2234020. Epub 2023 Jul 14. Cutan Ocul Toxicol. 2023. PMID: 37452558 Review.
BACKGROUND: sh-oligopeptide-1 is a cosmetic that is considered to be the bioequivalent of the Epidermal Growth Factor (EGF). ...Topical hr-EGF is not authorised as a medication in any concentration, except for clinical trials. However, sh-EGF (sh-oligopeptide …
BACKGROUND: sh-oligopeptide-1 is a cosmetic that is considered to be the bioequivalent of the Epidermal Growth Factor (EGF). ...Topic …
Kit (W-sh) Mutation Prevents Cancellous Bone Loss during Calcium Deprivation.
Lotinun S, Suwanwela J, Poolthong S, Baron R. Lotinun S, et al. Calcif Tissue Int. 2018 Jan;102(1):93-104. doi: 10.1007/s00223-017-0334-8. Epub 2017 Oct 14. Calcif Tissue Int. 2018. PMID: 29032463
The low calcium diet resulted in a comparable reduction in cortical bone volume and cortical thickness in the W/W (v) and W (sh) /W (sh) mice, and their corresponding controls. As expected, the low calcium diet induced cancellous bone loss in the W/W (v) mice. In co …
The low calcium diet resulted in a comparable reduction in cortical bone volume and cortical thickness in the W/W (v) and W (sh) /W ( …
63,557 results
You have reached the last available page of results. Please see the User Guide for more information.